Cardioprotective and Metabolic Effects of Metformin in Patients With Heart Failure and Diabetes

NCT01690091 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

40

Enrollment

OTHER_GOV

Sponsor class

Conditions

Insulin Resistance
Chronic Heart Failure

Interventions

DRUG: Metformini hydrochloridum (Siofor 1000 tbl, Berlin)
DRUG: placebo

Sponsor

Institute for Clinical and Experimental Medicine